Met Life Investment Management, LLC Kinnate Biopharma Inc. Transaction History

Met Life Investment Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2024	BUY	$3.46 - $7.98 $53,924 - $124,368	15,585 New	15,585 $97.4 Million
Q1 2022 May 10, 2024	BUY	$7.73 - $17.99 $120,472 - $280,374	15,585 New	15,585 $175,000
Q1 2022 Mar 22, 2023	BUY	$7.73 - $17.99 $43,736 - $101,787	5,658 Added 57.0%	15,585 $175,000
Q1 2022 May 12, 2022	BUY	$7.73 - $17.99 $43,736 - $101,787	5,658 Added 57.0%	15,585 $175,000
Q4 2021 Jun 21, 2023	SELL	$16.5 - $25.48 $93,357 - $144,165	-5,658 Reduced 36.3%	9,927 $175,000
Q3 2021 May 17, 2024	BUY	$17.81 - $24.87 $62,441 - $87,194	3,506 Added 54.6%	9,927 $228,000
Q3 2021 Jun 21, 2023	SELL	$17.81 - $24.87 $100,768 - $140,714	-5,658 Reduced 36.3%	9,927 $228,000
Q3 2021 Mar 22, 2023	BUY	$17.81 - $24.87 $62,441 - $87,194	3,506 Added 54.6%	9,927 $228,000
Q3 2021 Nov 15, 2021	BUY	$17.81 - $24.87 $176,799 - $246,884	9,927 New	9,927 $229,000
Q2 2021 Aug 16, 2021	SELL	$22.19 - $31.55 $142,481 - $202,582	-6,421 Closed	0 $0
Q1 2021 May 17, 2024	BUY	$26.99 - $40.0 $173,302 - $256,840	6,421 New	6,421 $200,000
Q1 2021 Jun 26, 2023	SELL	$26.99 - $40.0 $247,336 - $366,560	-9,164 Reduced 58.8%	6,421 $200 Million
Q1 2021 Mar 22, 2023	SELL	$26.99 - $40.0 $247,336 - $366,560	-9,164 Reduced 58.8%	6,421 $200,000
Q1 2021 May 14, 2021	BUY	$26.99 - $40.0 $173,302 - $256,840	6,421 New	6,421 $200,000

292K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.